Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Manchester, United Kingdom). Recommendations for bronchodilators and PDE4 inhibitors for prevention of exacerbations of COPD. International Congress 2017 – Treatment and prevention of COPD exacerbation

Member's Comments

No comment yet.

Related content which might interest you: Recommendations for pharmacological treatment of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Efficacy of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis Source: Annual Congress 2009 - Treatment of COPD Year: 2009 Safety of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis Source: Annual Congress 2009 - Treatment of COPD Year: 2009 Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Corticosteroids and exacerbations of COPD Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Reduction in systemic inflammation by the PDE4 inhibitor roflumilast in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 The role of bronchodilator treatment in the prevention of exacerbations of COPD Source: Eur Respir J 2012; 40: 1545-1554 Year: 2012 Prevention of COPD exacerbations: medications and other controversies Source: ERJ Open Res 2015; 1: 00011-2015 Year: 2015 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Oral immunotherapy in preventing exacerbations of COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 The direct costs of exacerbations in COPD and the effect of cilomilast treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 Inhaled steroids in exacerbations of COPD Source: Eur Respir J 2007; 30: 398 Year: 2007 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013